Studies have shown that even after clinical onset of AD, increasing the expression of BDNF by modulating the mRNA level of CREB may spare patients from memory deficits and cognitive dysfunction (Rosa and Fahnestock, 2015). Here, BDNF is linked to Alzheimer disease.